IL6 and non-small cell lung carcinoma: In NSCLC, IL-6 induces TGFβ-mediated EMT through the IL-6/Janus kinase (JAK)/STAT signaling pathway, thereby enhancing metastatic potential via activation of nuclear factor kappa-B (NF-κB) signaling [15].